A new platelet polymorphism Duva+, localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia

Blood

Volumn 99, Issue 12, 2002, Pages 4449-4456

  Jallu, Vincent ^a,b   Meunier, Marc ^a,b   Brément, Maryline ^a,b   Kaplan, Cécile ^a,b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b CH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CALCIUM ION; COMPLEMENTARY DNA; DITHIOTHREITOL; EPITOPE; FIBRINOGEN; GLYCOPROTEIN IIIA; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAC 1; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; BLOOD DONOR; CASE REPORT; CELL STRAIN COS7; CHO CELL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EXON; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NEWBORN; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

EID: 0037097582     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.12.4449     Document Type: Article

References (51)

1. Integrins: Versatility, modulation, and signaling in cell adhesion
2. Role of fibrinogen α and β chain sites in platelet aggregation
3. The AGDV residues on the γ chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation
4. The human platelet alloantigens, PIA1 and PIA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
5. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system
6. Amino acid 489 is encoded by a mutational "hot spot" on the β-3 integrin chain: The CA/TU human platelet alloantigen system
7. Single point mutation in human glycoprotein IIIa is associated with a new plateletspecific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia
8. A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet β3 integrin subunit. The Sra alloantigen system of GPIIIa
9. HPA-10wb (Laa): Genetic determination of a new platelet specific alloantigen on glycoprotein IIIa and its expression in cos-7 cells
10. The Arg633His substitution responsible for the private platelet antigen Groa unravelled by SSCP analysis and direct sequencing
11. One amino acid deletion of the PLA2 allelic form of GP IIIa leads to the formation of the new platelet alloantigen, Oe(a)
12. Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system
13. Maxa, a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia
14. A new low-frequency platelet alloantigen, Vaa, on glycoprotein IIbIIIa associated with neonatal alloimmune thrombocytopenia
15. Frequency of immune thrombocytopenia in newborns: A prospective study
16. 348 Cases of suspected neonatal allo-immune thrombocytopenia
17. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: Clinical and immunological analysis of 39 cases
18. The human platelet alloantigens Bra and Brb are associated with a single amino acid polymorphism on glycoprotein la (integrin subunit a2)
19. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies
20. A simple salting out procedure for extracting DNA from human nucleated cells
21. Rapid typing for human platelet antigen systems -1, -2, -3 and -5 by PCR amplification with sequence specific primers
22. Localization of the Br polymorphism on a 144 bp exon of the GPIa gene and its application in platelet DNA typing
23. Genotype frequencies of the human platelet antigen, Ca/Tu, in Japanese, determined by a PCR-RFLP method
24. Two human antibodies reacting with different epitopes on integrin β 3 of platelets and endothelial cells
25. Human platelet antigen genotyping using a fluorescent SSCP technique with an automatic sequencer
26. The genomic organization of platelet glycoprotein IIIa
27. Integrin-mediated activation of focal adhesion kinase is independent of focal adhesion formation or integrin activation. Studies with activated and inhibitory β3 cytoplasmic domain mutants
28. Activation-independent exposure of the GPIIb-IIIa fibrinogen receptor
29. Distinct involvement of β3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signalling
30. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor
31. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen
32. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIbIIIa complex, with intact platelets
33. Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets
34. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope
35. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PIA1: Evidence for heterogeneity in the humoral response
36. The impact of three-dimensional structure on the expression of PIA alloantigens on human integrin β3
37. On the association of the plateletspecific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa
38. Effect of the binding of anti-Zwa antibodies on platelet function
39. Fetal bleeding in neonatal alloimmune thrombocytopenia mediated by antiPIA1 is not associated with inhibition of fibrinogen binding to platelet GP IIb/IIIa
40. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide
41. Ligand binding to integrin aIIbβ3 is dependent on a MIDAS-like domain in the β3 subunit
42. Evidence that the integrin β3 and β5 subunits contain a metal ion-dependent adhesion site-like motif but lack an 1 domain
43. Identification of a region in the integrin β3 subunit that confers ligand binding specificity
44. A Leu 117→-Trp mutation within the RGD-peptide cross-linking region of β3 results in Glanzmann thrombasthenia by preventing aIIbβ3 export to the platelet surface
45. A β3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation
46. Mutation of a ligand binding domain of β 3 integrin. Integral role of oxygenated residues in aIIb β 3 (GP IIb-IIIa) receptor function
47. Activation of the fibrinogen binding site on platelet isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia
48. A spontaneous mutation of integrin aIIbβ3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site
49. Type II Glanzmann thrombasthenia due to a destabilizing amino acid substitution in platelet membrane glycoprotein IIIa
50. Peptide ligands can bind to distinct sites in integrin aIIbβ3 and elicit different functional responses
51. Adhesive and signaling properties of a naturally occurring allele of glycoprotein IIIa with an amino acid substitution within the ligand binding domain - The Pena/Penb platelet alloantigenic epitopes